The guidance aims to help accelerate the development of new antibiotics for severe, drug-resistant gram-negative and gram-positive infections and community-acquired and healthcare-associated bacterial ...
Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results